peptide elongation factor 2 has been researched along with Cystic Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buyck, J; Cougoule, C; Gorse, L; Guet-Revillet, H; Henras, A; Hessel, A; Leon-Icaza, SA; Mazars, R; Meunier, E; Murris, M; Paradis, M; Péricat, D; Pinilla, M; Planès, R; Prouvensier, L; Ravet, E; Robinson, KS; Santoni, K; Suire, B; Toh, GA; Vergé, R; Zhong, FL | 1 |
| Apaja, PM; Bidaud-Meynard, A; Guo, J; Hartman, JL; Icyuz, M; Lin, ST; Lukacs, GL; Oliver, K; Perdomo, D; Sorscher, EJ; Veit, G | 1 |
2 other study(ies) available for peptide elongation factor 2 and Cystic Fibrosis
| Article | Year |
|---|---|
EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption.
Topics: Cystic Fibrosis; Cytoplasm; Eukaryota; Humans; Inflammasomes; NLR Proteins; Peptide Elongation Factor 2 | 2023 |
Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect.
Topics: Aminopyridines; ATP-Binding Cassette Transporters; Benzodioxoles; Bronchi; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Gene Knockdown Techniques; Gene Silencing; High-Throughput Screening Assays; Humans; Peptide Elongation Factor 2; Protein Folding; Protein Stability; Ribosomal Proteins; RNA, Small Interfering; Saccharomyces cerevisiae Proteins; Yeasts | 2016 |